A detailed history of Sandy Spring Bank transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Sandy Spring Bank holds 3,300 shares of PMN stock, worth $3,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,300
Previous 3,300 -0.0%
Holding current value
$3,794
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$1.28 - $2.81 $4,224 - $9,273
3,300 New
3,300 $6,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.